13F-HR filed by JOHNSON & JOHNSON
JOHNSON & JOHNSON filed this 13F-HR for the quarter ended 2023-09-30, filed 2023-11-09, with 24 holding rows worth $271,470,815.
- Accession
- 0000904454-23-000600
- Filer
- CIK 200406
- Filed
- 2023-11-09
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2023
A holdings report, 24 entries on the cover page, a total value of $271,470,815 stated on the cover page (in dollars after the unit check, H1), rows summing to $271,470,815 with VALUE read as dollars as filed, 13F file number 028-20072. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerJohnson & Johnson Innovation - JJDC, Inc.028-20073
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 814,586 | $54,715,742 | dollars as filed | |
| CVRX INC | 126638105 | COMMON STOCK | 3,495,575 | $53,027,873 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 2,449,183 | $40,852,372 | dollars as filed | |
| MEIRAGTX HOLDINGS PLC | G59665102 | COMMON STOCK | 6,641,064 | $32,607,624 | dollars as filed | |
| XENCOR INC | 98401F105 | COMMON STOCK | 748,062 | $15,073,449 | dollars as filed | |
| NEUMORA THERAPEUTICS INC. | 640979100 | COM | 912,128 | $12,870,126 | dollars as filed | |
| PROCEPT BIOROBOTICS CORP COM | 74276L105 | Stock | 357,939 | $11,743,979 | dollars as filed | |
| FUSION PHARMACEUTICALS INC | 36118A100 | COM | 3,670,516 | $9,543,342 | dollars as filed | |
| NANOBIOTIX | 63009J107 | SPONSORED ADS | 959,637 | $8,396,824 | dollars as filed | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 3,379,064 | $7,163,616 | dollars as filed | |
| POINT BIOPHARMA GLOBAL INC | 730541109 | COM | 1,000,000 | $6,670,000 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 247,598 | $6,652,958 | dollars as filed | |
| ALDEYRA THERAPEUTICS INC | 01438T106 | COM | 394,834 | $2,637,491 | dollars as filed | |
| CUE HEALTH INC | 229790100 | COM | 5,548,864 | $2,454,263 | dollars as filed | |
| VOR BIOPHARMA INC | 929033108 | COM | 1,074,658 | $2,278,275 | dollars as filed | |
| NANO X IMAGING LTD | M70700105 | ORD SHS | 317,704 | $2,084,138 | dollars as filed | |
| ADICET BIO INC | 007002108 | COM | 728,944 | $998,653 | dollars as filed | |
| BIOMX INC | 09090D103 | COM | 2,133,402 | $750,958 | dollars as filed | |
| SOMALOGIC INC | 83444K105 | COM | 281,052 | $671,714 | dollars as filed | |
| CLEARSIDE BIOMEDICAL INC | 185063104 | COM | 169,629 | $147,560 | dollars as filed | |
| APOLLOMICS INC | G0411D107 | COM | 13,252 | $49,629 | dollars as filed | |
| SENSEONICS HLDGS INC | 81727U105 | COM | 54,621 | $32,986 | dollars as filed | |
| CATALYST BIOSCIENCES INC | 14888D208 | COM | 66,951 | $32,290 | dollars as filed | |
| TRACON PHARMACEUTICALS INC | 89237H209 | COM NEW | 84,003 | $14,953 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000904454-23-000600 | this filing | 2023-11-09 | acceptance time not in the bulk data set |